JPMorgan sees 100% upside in overlooked cancer drug stock
The bank just put a big number on a small biotech company, and the target rests on a newly launched drug.
Read the full story at TST (Full) - (Official Feed) →
The bank just put a big number on a small biotech company, and the target rests on a newly launched drug.
Read the full story at TST (Full) - (Official Feed) →
€
€
€
€